Author = Omar M. Aly
| Number of Articles: 4 | ||
| 1 | HDAC as a cancer target: various scaffold. Based HDAC inhibitors and overview of their advances | |
| Articles in Press, Accepted Manuscript , Available Online from 02 May 2024 | ||
| abrar mortada abdelraheem; Omar M Aly; Mamdouh fawzy ahmed; Aliaa M mohassab | ||
| 2 | Hydantoin derivatives: A review on their anticancer activities | |
| Volume 4, Issue 1, January 2024, Page 61-74 | ||
| Moamen A. Hassanin; Muhamad Mustafa; Heba A. Hassan; Eman A Beshr; Ahmed T. M. Elshennawy; Omar M. Aly | ||
| 3 | Synthesis, Molecular Modeling and Anticancer Activity of New Rescinnamine Derivatives as MMR-Inducers | |
| Volume 2, Issue 1, January 2023, Page 21-35 | ||
| shimaa naguib; Omar Aly; Gamal Abourhma; Stephen King; Freddie Salsbury; Karin Scarpinato; Andrew Diamanduros | ||
| 4 | Design, synthesis in vitro and in vivo evaluation of new diaryltriazoles carboxylic and hydroxamic acid derivatives as inhibitors of tumor necrosis alpha converting enzyme (TACE) | |
| Volume 2, Issue 1, January 2023, Page 44-62 | ||
| Abdelfattah Hassan; Mostafa M. Badran; Heba A. Hassan; Dalia Abdelhamid; Omar Aly | ||
View on SCiNiTO